CA1334002C - Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferes - Google Patents
Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferesInfo
- Publication number
- CA1334002C CA1334002C CA 613762 CA613762A CA1334002C CA 1334002 C CA1334002 C CA 1334002C CA 613762 CA613762 CA 613762 CA 613762 A CA613762 A CA 613762A CA 1334002 C CA1334002 C CA 1334002C
- Authority
- CA
- Canada
- Prior art keywords
- epa
- gla
- composition
- dgla
- linolenic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25113988A | 1988-09-28 | 1988-09-28 | |
| US251,139 | 1988-09-28 | ||
| US40028889A | 1989-08-29 | 1989-08-29 | |
| US400,288 | 1989-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1334002C true CA1334002C (fr) | 1995-01-17 |
Family
ID=26941434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 613762 Expired - Lifetime CA1334002C (fr) | 1988-09-28 | 1989-09-27 | Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferes |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1334002C (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014037903A3 (fr) * | 2012-09-06 | 2014-07-31 | Dignity Sciences, Ltd. | Compositions cosmétiques comprenant epa et gla et leurs procédés de fabrication et d'utilisation |
| US10849870B2 (en) | 2014-06-04 | 2020-12-01 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and use of same |
| US12017986B2 (en) | 2015-05-13 | 2024-06-25 | Ds Biopharma Limited | Compositions comprising oxo-derivatives of fatty acids and methods of making and using same |
| US12076304B2 (en) | 2020-04-03 | 2024-09-03 | Afimmune Limited | Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases |
-
1989
- 1989-09-27 CA CA 613762 patent/CA1334002C/fr not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014037903A3 (fr) * | 2012-09-06 | 2014-07-31 | Dignity Sciences, Ltd. | Compositions cosmétiques comprenant epa et gla et leurs procédés de fabrication et d'utilisation |
| CN104994911A (zh) * | 2012-09-06 | 2015-10-21 | 尊贵科学有限公司 | 包括二十碳五烯酸游离酸和γ-亚麻酸游离酸的化妆品组合物及其制造和使用方法 |
| AU2013311238B2 (en) * | 2012-09-06 | 2018-02-22 | Afimmune Limited | Cosmetic Compositions Comprising EPA and GLA and Methods of Making and Using Same |
| CN104994911B (zh) * | 2012-09-06 | 2018-11-27 | Af免疫有限公司 | 包括二十碳五烯酸游离酸和γ-亚麻酸游离酸的化妆品组合物及其制造和使用方法 |
| US10849870B2 (en) | 2014-06-04 | 2020-12-01 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and use of same |
| US11478442B2 (en) | 2014-06-04 | 2022-10-25 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and use of same |
| US12017986B2 (en) | 2015-05-13 | 2024-06-25 | Ds Biopharma Limited | Compositions comprising oxo-derivatives of fatty acids and methods of making and using same |
| US12076304B2 (en) | 2020-04-03 | 2024-09-03 | Afimmune Limited | Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5059622A (en) | Method for reducing blood pressure levels in hypertensive persons | |
| US10342773B2 (en) | Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient | |
| RU2276975C2 (ru) | Терапевтические комбинации жирных кислот | |
| US5589508A (en) | Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases | |
| JP2796838B2 (ja) | 精神分裂症および／または関連した晩発性運動障害の治療のための薬剤を製造する方法 | |
| US4970076A (en) | Fatty acid composition | |
| JP3559039B2 (ja) | 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用 | |
| US20110015160A1 (en) | Methods of treating neurological diseases using docosahexaenoic acid and arachidonic acid compositions | |
| US4058594A (en) | Immuno-suppressive agents | |
| WO2006017627A2 (fr) | Compositions dietetiques et procedes d'utilisation dans le traitement de l'insulinoresistance | |
| US20060078625A1 (en) | Compositions including krill extracts and conjugated linoleic acid and methods of using same | |
| JP2005535733A (ja) | ドライアイ、マイボーム腺炎及び口内乾燥症の治療用ｅｐａ及びｄｈａ富化オメガ−３補給剤 | |
| MXPA04008711A (es) | Tratamiento y prevencion de trastornos inflamatorios. | |
| JPH06157303A (ja) | 脂肪酸治療 | |
| JPH04342525A (ja) | ホスホリパーゼａ２抑制用薬剤の製造方法 | |
| US6280755B1 (en) | Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals | |
| US20040208939A1 (en) | Novel dietary compositions to reduce inflammation | |
| EP1886679A2 (fr) | Procédés de contrôle de contenu d'acide gras hautement non saturés dans plusieurs tissus | |
| KR20080027279A (ko) | 주간 활동량 감소 증상 및/또는 우울 증상의 개선용 조성물 | |
| US4898885A (en) | Pharmaceutica and dietary compositions | |
| US5922345A (en) | Nutrition | |
| JPH04290821A (ja) | 液体栄養副作用の予防方法またはそれに用いる薬剤の製造方法 | |
| CN112107570A (zh) | 施用包含二十二碳五烯酸的组合物的方法 | |
| CA1334002C (fr) | Compositions a base d'acides gras essentiels et methodes de modulation de la concentration des prostaglandines chez les mammiferes | |
| JP2006306813A (ja) | 肥満細胞増殖抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |